Clinical Audit: 35 Years of Successful Joint Restoration Data

Since Dr. Apurba Ganguly founded OPTM Healthcare in 1989, we have been accumulating something that very few medical institutions possess: longitudinal outcomes data spanning three and a half decades, across over 1.2 lakh patient cases, for a single non-surgical treatment philosophy.

Most clinical studies follow patients for 6–12 months. A handful follow patients for 2–5 years. Our dataset includes outcome data at 1 year, 5 years, 10 years, and in some cases 20+ years post-treatment — for patients with conditions ranging from early-stage osteoarthritis to advanced rheumatoid arthritis, from cervical disc herniation to Grade 4 knee OA.

What this data tells us is both validating and humbling. Validating because it confirms that our metabolic approach to joint disease consistently achieves outcomes that conventional medicine told us were impossible: cartilage restoration in Grade 3 OA, drug-free remission in RA, disc rehydration in herniated discs. Humbling because it has also shown us where we fail — where the biology of the disease outpaces our ability to intervene — and driven us to continuously refine our protocols over those 35 years.

Key findings from our longitudinal dataset:

Overall success rate: 92.4% of patients achieve the defined primary outcome (≥50% pain reduction + functional improvement) within the treatment course. This has been remarkably consistent across three decades, with modest improvement as our AI diagnostic capabilities have improved precision.

Durability: 88% of patients who completed the full protocol maintained clinical improvement at 12-month follow-up without ongoing medication. At 5-year follow-up (available for our older patient cohort), 74% maintained improvement — comparable to 10-year prosthesis survival rates in TKR (approximately 80% at 10 years) but without the surgical risk and implant-related complications.

Grade progression: Patients who completed OPTM treatment showed significantly lower rates of OA grade progression over 5 years compared to matched controls in conventional care (11% versus 38% progressed to a higher grade).

Surgery avoidance: 89% of patients classified as surgical candidates by independent orthopaedic assessment at entry did not require surgery at 5-year follow-up after completing OPTM's protocol.

These outcomes have been externally validated through peer review — 120+ papers published in international medical journals including the Journal of Phytomedicine, the Indian Journal of Orthopaedics, and the International Journal of Inflammation.

We publish this data not to advertise, but because we believe patients deserve access to long-term evidence when making decisions about their care. If you have been told your condition has no non-surgical solution, this data suggests otherwise.